305 related articles for article (PubMed ID: 33400975)
21. A review of monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection.
Tabll AA; Shahein YE; Omran MM; Elnakib MM; Ragheb AA; Amer KE
Hum Antibodies; 2021; 29(3):179-191. PubMed ID: 33998533
[TBL] [Abstract][Full Text] [Related]
22. Thinking more about therapy with convalescent plasma for COVID-19 patients.
Han G; Zhou YH
Hum Vaccin Immunother; 2020 Nov; 16(11):2601-2603. PubMed ID: 32643512
[No Abstract] [Full Text] [Related]
23. Antibody therapy for COVID-19.
Hammarström L; Marcotte H; Piralla A; Baldanti F; Pan-Hammarström Q
Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):553-558. PubMed ID: 34570010
[TBL] [Abstract][Full Text] [Related]
24. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
Panovska-Stavridis I; Ridova N; Stojanoska T; Demiri I; Stevanovic M; Stojanovska S; Ristevska T; Dimkovski A; Filipce V; Dimovski A; Grozdanova A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Apr; 42(1):5-18. PubMed ID: 33894123
[TBL] [Abstract][Full Text] [Related]
25. Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment Pathway.
D'Abramo A; Vita S; Maffongelli G; Beccacece A; Agrati C; Cimini E; Colavita F; Giancola ML; Cavasio A; Nicastri E;
Front Immunol; 2022; 13():911339. PubMed ID: 35711444
[TBL] [Abstract][Full Text] [Related]
26. Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies.
Hassan M; Zalkifal M; Wahab A; Afzal S; Rafique S; Shahid M; Khan MA; Ahmed N; Idrees M; Shahid AA
Crit Rev Eukaryot Gene Expr; 2021; 31(3):21-34. PubMed ID: 34369712
[TBL] [Abstract][Full Text] [Related]
27. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
Majumder J; Minko T
AAPS J; 2021 Jan; 23(1):14. PubMed ID: 33400058
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 Drug Development.
Kim S
J Microbiol Biotechnol; 2022 Jan; 32(1):1-5. PubMed ID: 34866128
[TBL] [Abstract][Full Text] [Related]
29. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
[TBL] [Abstract][Full Text] [Related]
30. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
Lu L; Zhang H; Zhan M; Jiang J; Yin H; Dauphars DJ; Li SY; Li Y; He YW
Sci China Life Sci; 2020 Dec; 63(12):1833-1849. PubMed ID: 33355886
[TBL] [Abstract][Full Text] [Related]
31. Clearance of the SARS-CoV-2 Virus in an Immunocompromised Patient Mediated by Convalescent Plasma without B-Cell Recovery.
Basheer M; Saad E; Laskar O; Schuster O; Rechnitzer H; Zisman-Rozen S; Azoulay D; Assy N
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445605
[TBL] [Abstract][Full Text] [Related]
32. COVID-19 Therapeutics for Solid Organ Transplant Recipients; 6 Months Into the Pandemic: Where Are We Now?
Avery RK
Transplantation; 2021 Jan; 105(1):56-60. PubMed ID: 33141805
[TBL] [Abstract][Full Text] [Related]
33. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19.
Sewell HF; Agius RM; Kendrick D; Stewart M
BMJ; 2020 Jul; 370():m2722. PubMed ID: 32646867
[No Abstract] [Full Text] [Related]
34. Possible treatment and strategies for COVID-19: review and assessment.
Trivedi N; Verma A; Kumar D
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12593-12608. PubMed ID: 33336780
[TBL] [Abstract][Full Text] [Related]
35. Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection.
Hosseini P; Rahimi H; Najafabadi MM; Ghorbani A; Najafabadi SK; Faridzadeh A; Arabpour J; Khormali E; Deravi N
Acta Med Indones; 2021 Jan; 53(1):86-95. PubMed ID: 33818411
[TBL] [Abstract][Full Text] [Related]
36. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
Wooding DJ; Bach H
Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
[TBL] [Abstract][Full Text] [Related]
37. Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions.
Shah M; Woo HG
Mol Cells; 2021 Jun; 44(6):408-421. PubMed ID: 34059561
[TBL] [Abstract][Full Text] [Related]
38. Current Scenario and Future Prospect in the Management of COVID-19.
Borah P; Deb PK; Deka S; Venugopala KN; Singh V; Mailavaram RP; Kalia K; Tekade RK
Curr Med Chem; 2021; 28(2):284-307. PubMed ID: 32900341
[TBL] [Abstract][Full Text] [Related]
39. Convalescent blood plasma (CBP) donated by recovered COVID-19 patients - A comment.
Lung T; Sakem B; Risch M; Nydegger U
Transfus Apher Sci; 2021 Jun; 60(3):103108. PubMed ID: 33678561
[No Abstract] [Full Text] [Related]
40. SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model.
Haagmans BL; Noack D; Okba NMA; Li W; Wang C; Bestebroer T; de Vries R; Herfst S; de Meulder D; Verveer E; van Run P; Lamers MM; Rijnders B; Rokx C; van Kuppeveld F; Grosveld F; Drabek D; Geurts van Kessel C; Koopmans M; Bosch BJ; Kuiken T; Rockx B
J Infect Dis; 2021 Jun; 223(12):2020-2028. PubMed ID: 34043806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
